Valeant Pharmaceuticals International (VRX) is considering the sale of an Egyptian drug maker it bought last year, Bloomberg’sManuel Baigorri and Dinesh Nair are reporting:
Valeant Pharmaceuticals International Inc. is considering the sale of Egyptian drugmaker Amoun Pharmaceutical Co. as the beleaguered Canadian company seeks to accelerate its debt-reduction plans, according to people with knowledge of the matter.
Amoun may attract pharmaceutical companies with an interest in expanding in emerging markets, the people said, asking not to be identified because the deliberations are private. The Egyptian companys current executives could also pursue a management buyout with help from financial investors, though no final decision has been made, the people said.
Valeant is working with Goldman Sachs Group Inc. on the sale, which is at a preliminary stage, the people said. Valeant agreed to acquire Amouns holding company Mercury Holdings last year for about $800 million, plus some contingent payments. Valeants intentions at the time were to use Amoun as a platform to further expand in the Middle East and Africa.
Top Canadian Stocks To Own Right Now: Wells Fargo & Company(WFC)
- [By ]
San Francisco-based Wells Fargo & Co. (WFC) , struggling to recover from a series of regulatory penalties over allegedly aggressive sales practices, posted a 5.5% profit increase on a preliminary basis, noting that legal costs might have to be revised higher pending discussions with regulators over as much as $1 billion of new penalties related to auto insurance and mortgage-related violations.
- [By ]
So where do you find them? Well, preferred stocks trade just like common shares on one of the major stock exchanges. They are a popular fundraising tool for companies that need capital to grow and expand, but don’t want to borrow or issue more common stock. Well-known businesses like Ford Motor (NYSE: F), General Electric (NYSE: GE), Wells Fargo (NYSE: WFC) and T-Mobile (Nasdaq: TMUS) have all issued preferred stock.
- [By ]
JPMorgan Chase & Co. (JPM) , Citigroup Inc. (C) and Wells Fargo & Co. (WFC) each reported strong earnings beats Friday, April 13, kicking off what analysts expect to be a solid quarter for the sector.
- [By ]
He practices what he preaches. While Berkshire Hathaway has ownership interests in about 45 companies, the lion’s share of the portfolio (nearly two-thirds) is invested in just six names. The biggest is Apple (Nasdaq: AAPL), followed by Wells Fargo (NYSE: WFC), Kraft Heinz (Nasdaq: KHC), Bank of America (NYSE: BAC), Coca-Cola (NYSE: KO), and American Express (NYSE: AXP).Buffett isn’t afraid to make colossal investments in a small handful of positions. And with few exceptions, these big bets usually work out brilliantly. Of course, we’re also talking about the most astute stock picker of all time. For those without his legendary skills, this strategy might be far less productive — possibly even dangerous.
Top Canadian Stocks To Own Right Now: Valeant Pharmaceuticals International Inc(VRX)
- [By Dan Caplinger]
The stock market finally hit some resistance on Tuesday, giving up ground and breaking a long streak of consecutive advances for most major benchmarks. Market participants got spooked by a rise in interest rates, with 10-year Treasury yields once again climbing above the 3% mark and leading some to predict even steeper advances in the future. With budget deficits ballooning, higher interest expenses on the national debt could have a dramatic impact on the U.S. economy, especially if it lures investors away from high-flying stocks. Yet even amid the bond-driven downturn, some individual companies saw good news lift their shares. Valeant Pharmaceuticals International (NYSE:VRX), Hollysys Automation Technologies (NASDAQ:HOLI), and Ascena Retail Group (NASDAQ:ASNA) were among the best performers on the day. Here’s why they did so well.
- [By Lisa Levin] Gainers
Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
- [By Lisa Levin] Gainers
Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results.
LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat.
MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900.
SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results.
Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday.
Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat.
Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday.
Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday.
PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results.
Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday.
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy.
Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat.
Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o
- [By Dan Caplinger]
Tuesday saw an up-and-down session on Wall Street, with major benchmarks trading on either side of the unchanged mark before finishing the day flat. Many investors kept most of their attention on Washington, where the White House announced that the U.S. would withdraw from the deal that the previous administration made with Iran concerning nuclear development. The withdrawal was largely expected, and although crude oil and other commodities were volatile leading up to the final decision, most other financial markets seemed prepared for the announcement. Even on a lackluster day, some companies had good news that lifted their shares substantially. Expeditors International of Washington (NASDAQ:EXPD), Valeant Pharmaceuticals International (NYSE:VRX), and SeaWorld Entertainment (NYSE:SEAS) were among the best performers on the day. Here’s why they did so well.
- [By Lee Jackson]
This company has been fighting its way back now for over a year and may be a very solid contrarian play. Valeant Pharmaceuticals International Inc. (NYSE: VRX) operates as a multinational, specialty pharmaceutical and medical device company that develops, manufactures and markets a range of pharmaceuticals, over-the-counter (OTC) products and medical devices. The company operates through three segments: Bausch + Lomb/International, Branded Rx and U.S. Diversified Products.
Top Canadian Stocks To Own Right Now: Transcananda Pipelines Ltd.(TRP)
- [By Matthew DiLallo]
TransCanada’s (NYSE:TRP) expansion efforts continued paying dividends during the first quarter as earnings and cash flow kept growing. As a result, the Canadian pipeline giant remains on track to achieve its dividend growth targets. CEO Russ Girling affirmed that view on the quarterly conference call, where he detailed the company’s progress on its strategic plan.
- [By Matthew DiLallo]
Enbridge just bought its stake in the German offshore wind farm projectslast year, initially agreeing to invest about $1.25 billion for a 50% stake. However, with concerns growing about its balance sheet and ability to finance growth projects, the company has chosen to monetize part of this asset. It’s also monetizing its onshore renewable facilities in Canada and two in the U.S. to bring in some much-needed cash. This decision to cash in on a portion of its renewable portfolio follows a similar plan by fellow Canadian pipeline giant TransCanada (NYSE:TRP), which sold its solar assets in Ontario last year. The driving factor in that decision was TransCanada’s desire to improve its financial flexibility so that it could “continue to build on our vision of being North America’s leading energy infrastructure company,” said CEO Russ Girling. What’s clear from these deals is that neither TransCanada nor Enbridge sees renewables playing a key role in building the companies they envision themselves being.
- [By Dustin Parrett]
TransCanada Corp. (NYSE: TRP) just achieved a perfect Money Morning stock VQScore, making it a profit powder keg waiting to ignite…
TransCanada is a Canadian oil and gas pipeline company, most famous for its development of the Keystone XL pipeline connecting Canadian oil fields to major hubs in the United States.
- [By Paul Ausick]
In addition to the Trans Mountain system, two other pipeline projects currently are proposed to move crude oil from Alberta either to the Great Lakes or the Gulf Coast. Enbridge Inc. (NYSE: ENB) is proposing to replace its 50-year old Line 3 system to transport 760,000 barrels a day to Superior, Wisconsin. TransCanada Corp. (NYSE: TRP) has received approval from the Trump administration and would transport 830,000 barrels a day to Nebraska where existing pipelines will take over, sending the crude to U.S. refineries and Gulf Coast terminals.
- [By Matthew DiLallo]
TransCanada (NYSE:TRP) is a dividend lovers’ dream stock. The Canadian pipeline giant has increased its payout for 18 straight years, including 10.4% for 2018, and it now yields nearly 5%. There’s still plenty more growth coming down the pipeline given its forecast that the company can increase the payout at an 8% to 10% annual rate through at least 2021. That outlook is among the best in its peer group.
Top Canadian Stocks To Own Right Now: Canadian National Railway Company(CNI)
- [By Shane Hupp]
Get a free copy of the Zacks research report on Canadian National Railway (CNI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
WARNING: “Q3 2018 Earnings Estimate for Canadian National Railway (CNI) Issued By Cormark” was first posted by Ticker Report and is owned by of Ticker Report. If you are reading this piece on another publication, it was copied illegally and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3350637/q3-2018-earnings-estimate-for-canadian-national-railway-cni-issued-by-cormark.html.
- [By Motley Fool Staff]
Canadian National Railway Co (NYSE:CNI)Q1 2018 Earnings Conference CallApril 23, 2018, 4:30 p.m. ET
Prepared Remarks Questions and Answers Call Participants
- [By Paul Ausick]
GE got some good news this past week with an order for 200 locomotives from Canadian National Railway Co. (NYSE: CNI). The locomotives will be built at GE’s plant in Fort Worth, Texas, and deliveries to the rail operator will begin next year. The balance of the locomotives will be delivered in 2019 and 2020.
Top Canadian Stocks To Own Right Now: Prestige Brand Holdings Inc.(PBH)
- [By Stephan Byrd]
Premium Brands (TSE:PBH) had its target price increased by TD Securities from C$140.00 to C$145.00 in a research note published on Thursday. The firm currently has an action list buy rating on the stock.
- [By Ethan Ryder]
Premium Brands (TSE:PBH) will be announcing its earnings results before the market opens on Tuesday, May 15th. Analysts expect the company to announce earnings of C$0.71 per share for the quarter.
- [By Lisa Levin]
Prestige Brands Holdings, Inc. (NYSE: PBH) shares were also up, gaining 23 percent to $35.07 after the company posted upbeat Q4 earnings.
Equities Trading DOWN